Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Dezember 2025 09:15 ET | Quelle: Longeveron

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

Longeveron granted US patent for method of treating female sexual dysfunction using its proprietary stem cell therapy laromestrocel.
05. April 2024 04:34 ET | Quelle: Research and Markets

Female Sexual Dysfunction (FSD) Clinical Landscape Report 2024: Only 3 Out of 24 Drugs in the Pipeline are in the Phase III Stage of Development

Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Female Sexual Dysfunction (FSD) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This report offers a...
19. Dezember 2022 08:00 ET | Quelle: Oncotelic Therapeutics, Inc.

Oncotelic Presents Clinical Data of Confirming TGF-β2 as the appropriate target for gliomas at JCA-AACR Meeting 2022

-Reduced TGF-β2, but not TGF-β1 nor TGF-β3, is associated with improved OS. AGOURA HILLS, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the...